CLPT Q2 2019 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$344M

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M+58.3% YoY

Gross Profit

$2M60.5% margin

Operating Income

-$1M-49.6% margin

Net Income

-$2M-59.5% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

-$810,107

Free Cash Flow

-$810,107

Stock-Based Comp.

$203,994

Balance Sheet

Total Assets

$13M

Total Liabilities

$6M

Stockholders' Equity

$7M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+58.3%
Gross Profit	$2M	$1M	+51.0%
Operating Income	-$1M	-$2M	+21.0%
Net Income	-$2M	-$2M	+17.4%

Revenue Segments

Product Revenues

$2M42%

Functional Neurology

$2M32%

Service and Other Revenues

$412,2048%

Biologics And Drug Delivery

$244,9495%

Capital Equipment and Other

$243,9545%

Capital Equipment

$241,2935%

BiologicsAndDrugDelivery1Member

$168,2503%

Therapy

$17,8300%